Skip to content

Milestone Pharmaceuticals Inc.

MIST

CIK 0001408443

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$71.72M
−51.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.83
−11.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$52.93M
Q1 May 2026
Cash
$71.32M
Q1 May 2026
Total Debt
$58.19M
Q1 May 2026
Shares Outstanding
124.5M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings